NCF2 rs119103275: Understanding This Rare Genetic Variant
The rs119103275 variant is a rare genetic change located within the NCF2 gene. It has been identified in research contexts as being associated with chronic granulomatous disease, a condition that affects the immune system's ability to fight certain infections.
What each genotype means
Typical NCF2 genotype
This is the most common genotype observed in the general population. It is considered the reference state, meaning it does not contain the specific rare variant associated with the studied NCF2-related conditions.
This is the predominant genotype found across all major global populations.
Carrier of rare variant
You carry one copy of this rare variant. While NCF2 variants are linked to autosomal recessive conditions like chronic granulomatous disease, carrying a single copy typically does not cause the disease, though you should consult with a genetic counselor to understand your specific risk profile.
This genotype is rare and observed at very low frequencies in global population databases.
Potential NCF2 variant homozygote
You carry two copies of this rare variant. Because NCF2-related conditions are inherited in an autosomal recessive manner, this genotype may be associated with altered NADPH oxidase function or immune-related traits. Please discuss these results with a medical professional or clinical geneticist to determine if this finding is clinically relevant to your health.
This genotype is extremely rare and is typically only identified in clinical research settings or specific populations with high rates of consanguinity.
What is the rs119103275 Variant?
The rs119103275 variant is a specific change in the DNA sequence of the NCF2 gene. In genetics, an 'rsID' like rs119103275 acts as a unique identifier for a single nucleotide polymorphism (SNP), which is a variation at a single position in the DNA code. This particular variant is located on chromosome 1. Scientists track these variants to understand how differences in our genetic blueprint might influence health and disease. Because this variant is considered rare, it is not commonly found in the general population. Research into this specific site helps clinicians and scientists better understand the functional role of the NCF2 gene and how specific alterations can impact the body's biological pathways, particularly those involved in immune defense and inflammation.
The Role of the NCF2 Gene
The NCF2 gene provides instructions for making a protein called neutrophil cytosolic factor 2, often referred to as p67phox. This protein is a critical component of the NADPH oxidase complex, an enzyme system found primarily in white blood cells called neutrophils. The primary job of this complex is to produce superoxide, a molecule that helps the immune system destroy harmful bacteria and fungi. When the NCF2 gene functions normally, it ensures that the NADPH oxidase complex can assemble and activate correctly during an immune response. If the gene contains pathogenic variants that disrupt this process, the immune system may struggle to clear infections effectively, which is a hallmark of conditions like chronic granulomatous disease. Understanding this gene is essential for grasping how our bodies maintain immunity against pathogens.
Research and Clinical Associations
Scientific literature has linked variants in the NCF2 gene to chronic granulomatous disease (CGD), a rare primary immunodeficiency. In individuals with CGD, the body's inability to produce sufficient superoxide leads to recurrent, severe infections and inflammation. While many different mutations in NCF2 can contribute to this condition, the evidence for any single variant's impact is often derived from clinical case studies of affected families. Research indicates that NCF2 mutations account for a small percentage of all CGD cases, making them less common than mutations in other genes like CYBB. Because the evidence for specific variants like rs119103275 is often based on rare clinical presentations, the strength of the association can vary. It is important to note that genetic findings are complex, and the presence of a variant does not automatically guarantee a specific health outcome.
Population Frequency and Interpretation
The rs119103275 variant is classified as rare, meaning it appears at a very low frequency in the general population. Genetic databases like gnomAD track the prevalence of such variants across diverse ancestral groups to help researchers determine if a variant is common or potentially significant. For rare variants, the frequency is often so low that it may not be detected in standard population samples. When interpreting genetic information, it is crucial to remember that rare variants require careful clinical evaluation. If you have received information about this variant from a genetic test, it is best to discuss the results with a qualified healthcare provider or a genetic counselor. They can provide context based on your personal and family medical history, helping you understand what the information means for your health and whether any further action is necessary.
What You Can Do With This Information
Genetic information is a tool for understanding your biological predispositions, but it should never be used to self-diagnose or make medical decisions without professional guidance. If you are concerned about your immune health or have a family history of recurrent infections, consult with an immunologist or a primary care physician. They can order appropriate diagnostic tests and interpret them in the context of your overall health. Avoid making changes to your lifestyle or medical regimen based solely on a genetic report. If a variant is linked to medication response, always consult your clinician or pharmacist before adjusting any prescriptions. Genetic testing provides data, but clinical expertise is required to translate that data into meaningful health management strategies that are safe and appropriate for your specific needs.
How common is this variant?
The rs119103275 variant is considered rare across global populations, with the variant allele appearing at a very low frequency in standard genetic databases.
Frequently asked questions
What is chronic granulomatous disease?
Chronic granulomatous disease (CGD) is a rare inherited disorder where the immune system cannot effectively kill certain bacteria and fungi. This happens because the body's white blood cells are unable to produce the necessary chemicals to destroy these invaders.
Does having this variant mean I have CGD?
No, having a genetic variant does not automatically mean you have a disease. Many factors, including the specific type of mutation and whether you have one or two copies, influence health outcomes; always consult a doctor for clinical interpretation.
How is NCF2 related to the immune system?
The NCF2 gene produces a protein that helps assemble the NADPH oxidase complex. This complex is essential for neutrophils to create the oxidative burst needed to eliminate pathogens.
Should I be worried about this variant?
Genetic variants are common, and most do not cause health issues. If you are concerned about a specific result, speak with a genetic counselor who can explain the findings in the context of your personal health.
Where can I find more information on NCF2?
You can find reliable information on the NCF2 gene through resources like MedlinePlus Genetics or the NCBI Gene database. These sites provide summaries of gene function and their known associations with various health conditions.
Sources & further reading
Educational information only, last refreshed 9/26/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs119103275?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29